Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 13, 2024.
All times in Eastern Daylight Time.
-
CAPITAL BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Capital Bancorp, Inc. - CBNKNEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Capital... more »
-
ENDEAVOR GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Endeavor Group Holdings, Inc. - EDRNEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Endeavor ... more »
-
DOMA HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Doma Holdings, Inc. - DOMANEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Doma Hold... more »
-
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart FailureBURLINGTON, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular... more »
-
ウィプロ、APMEA戦略市場部門の最高経営責任者にヴィナイ・フィラキを任命ドバイ、アラブ首長国連邦&ベンガルール、インド--(BUSINESS WIRE)--(ビジネスワイヤ) -- テクノロジー・サービスおよびコンサルティングの大手企業であるウィプロ・リミテッド(NYSE:WIT、BSE:507685、NSE:WIPRO)は、APMEA(アジア太平洋・インド・中東・アフリカ)戦略市場部門(SMU)の最高経営責任者(CEO)にヴィナイ・フィラキを任命したことを発表... more »
-
Stronghold通过战略收购20022 Labs强化支付网络旧金山--(BUSINESS WIRE)--(美国商业资讯)-- Stronghold(一家领先的创新数字支付解决方案公司)今天宣布收购20022 Labs。后者是一家推行ISO 20022金融报文传送标准的前沿公司。本次战略收购显著强化了Stronghold自有的支付网络StrongholdNET,并进一步与ISO 20022标准接轨。 20022 Labs专长于丰富数据型支付处理,将为S... more »
-
Stronghold透過對20022 Labs的策略性收購強化支付網路舊金山--(BUSINESS WIRE)--(美國商業資訊)-- 創新數位支付解決方案領域的領導者Stronghold今天宣布收購推進ISO 20022金融訊息傳遞標準的先驅20022 Labs。這一策略性措施顯著強化了Stronghold的專有支付網路StrongholdNET,使其進一步與ISO 20022標準接軌。 20022 Labs以其在涉及豐富資料的支付處理方面的專長而聞名,將為... more »
-
Arasan整合CSI和C-PHY的Total MIPI摄像头IP解决方案获得ISO26262认证加利福尼亚州圣何塞--(BUSINESS WIRE)--(美国商业资讯)-- Arasan是移动存储和连接IP解决方案的领先提供商。该公司自豪宣布,其Total MIPI摄像头IP解决方案作为单一产品获得ISO26262功能认证。该无缝集成整合解决方案可在传输模式下配置MIPI CSI-2 IP和MIPI C-PHY Tx IP,或是在接收模式下配置MIPI CSI-2 Rx IP和MIPI... more »
-
EXAI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Exscientia plcSAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct more »
-
AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations Akero Therapeutics, Inc. (AKRO) Misled Investors Regarding Viability and Efficacy of its Trial Drug Candidate more »
-
MBUU Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Malibu Boats, Inc.SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating the Allegations that Malibu Boats, Inc. (MBUU) Manipulated its Inventory to Show Greater Profit more »
-
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class ActionSAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating the Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability and Efficacy of its Weight Loss Drug more »
-
Almonty Receives Further Commitments For A$1.9M Under Previously Announced PlacementTORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce that following its March 2024 Placement, ... more »
-
AXT, Inc. (AXTI) Investor Notice: Robbins LLP Reminds Stockholders of the AXT, Inc. (AXTI) Class ActionSAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating the Allegations that AXT, Inc. (AXTI) Misled Investors Regarding its Business Operations more »
-
Pembina Pipeline Corporation Reports Voting Results from 2024 Annual Meeting of ShareholdersCALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) reported the voting results from its annual meeting of common shareholders held vi... more »